Researchers are currently exploring strategies to mitigate potential peripheral effects of G-CSF by administering it intrathecally in ALS, however, the harmful effects due to its invasive nature should not be ignored. This evidence concerns the gene CSF3 and amyotrophic lateral sclerosis.